Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
255.60    3.60 (1.43%)
Bid:
255.40
Ask:
256.00
Spread: 0.60 (0.235%)
Market Cap: £644.08m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Board updates

8 Mar 2023 16:26

RNS Number : 3439S
Genuit Group PLC
08 March 2023
 

8 March 2023

 

Genuit Group plc

 

Board updates

 

In accordance with FCA Listing Rule 9.6.11, Genuit Group plc (the 'Company') announces that Mark Hammond, Non-Executive Director, Senior Independent Director ('SID') and member of the Audit, Nomination and Remuneration Committees, has today stepped down from his role as SID but has agreed to remain on the Board beyond the completion of his nine-year term in April 2023. Given Mr Hammond's extensive experience of the Group, the need to onboard two new Non-Executive Directors and the requirement for an orderly handover, the Board is of the view that an extension to Mr Hammond's term is in the best interests of the Company. Having assessed Mr Hammond's independence, the Board has confirmed that in their view, he remains an independent Non-Executive Director of the Board and that his nine-year tenure does not impair his ability to challenge independently. The expectation is that Mr Hammond will retire from the Board in October 2023.

 

Lisa Scenna will take over as SID with effect from 8 March 2023. Ms Scenna has been a Non-Executive Director of the Company since September 2019 and is the Chair of the Remuneration Committee and a member of the Audit and Nomination Committees.

 

 

For further information please contact:

 

 

 

Emma Versluys +44 (0)1138 315315

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAJPMFTMTTMBIJ
Date   Source Headline
23rd Mar 20224:09 pmRNSDirector/PDMR Shareholding
22nd Mar 202211:57 amRNSBoard Committee changes
15th Mar 20227:00 amRNSFinal Results
10th Mar 20227:36 amRNSDirector Declaration
31st Jan 20223:10 pmRNSBoard changes update
9th Dec 20218:07 amRNSDirector Declaration
29th Nov 20218:01 amRNSDirectorate Change
16th Nov 20217:00 amRNSTrading Update
10th Nov 20218:02 amRNSDirector Declaration
1st Nov 20213:52 pmRNSBlock listing Interim Review
1st Nov 20218:43 amRNSDirector Declaration
29th Oct 202111:24 amRNSTotal Voting Rights
21st Oct 20214:11 pmRNSDirector/PDMR Shareholding
15th Oct 20215:07 pmRNSHolding(s) in Company
7th Oct 20217:31 amRNSDirector Declaration
8th Sep 202110:34 amRNSHolding(s) in Company
7th Sep 20213:17 pmRNSHolding(s) in Company
1st Sep 20214:00 pmRNSDirector/PDMR Shareholding
26th Aug 20215:14 pmRNSHolding(s) in Company
23rd Aug 20214:58 pmRNSHolding(s) in Company
20th Aug 202110:46 amRNSHolding(s) in Company
17th Aug 20217:00 amRNSHalf-year Report
28th May 20214:00 pmRNSTotal Voting Rights
24th May 20214:24 pmRNSDirector/PDMR Shareholding
20th May 202112:25 pmRNSResult of AGM
20th May 20217:01 amRNSBoard changes
20th May 20217:00 amRNSTrading Update
7th May 20215:23 pmRNSDirector/PDMR Shareholding
7th May 20215:00 pmRNSDirector/PDMR Shareholding
6th May 20215:28 pmRNSDirector/PDMR Shareholding
28th Apr 20214:11 pmRNSBlock Listing Application
19th Apr 20215:35 pmRNSNotice of AGM
8th Apr 20215:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.